Spanish Neurology Biotech Launches with €7.6M Series A
Accure Therapeutics, a neurology biotech targeting central nervous system (CNS) conditions such as multiple sclerosis…
Accure Therapeutics, a neurology biotech targeting central nervous system (CNS) conditions such as multiple sclerosis…
The Italian biotech Newron is halting the development of the experimental drug sarizotan after it…
The Paris-based BrainVectis, a biotech developing gene therapies for Huntington’s disease and Alzheimer’s disease, has…
The Swiss pharmaceutical company Idorsia has announced that its drug candidate daridorexant significantly improved sleep…
An epigenetics drug developed by the Spanish biopharmaceutical company Oryzon has reduced aggressive behavior in…
A deal between Swiss biotech AC Immune and Eli Lilly to develop an oral Alzheimer’s…
A drug developed by the French company MedDay Pharmaceuticals has failed to treat progressive forms…
An international group of researchers has set up a brain-machine interface between cultured nerve cells…
A project has launched with a €3.6M grant to treat neurological conditions such as Alzheimer’s…
Stalicla has bagged €16.3M in a Series A round to test drugs repurposed using AI…
With big pharma exiting the neurology space in droves, biotech innovation might be the key…
Orchard Therapeutics' gene therapy for metachromatic leukodystrophy (MLD) resulted in motor ability improvements more than…